AccentedTouch

A new study that was released last august issue of diabetes Care shows that by replacing carbohydrates with about 2 ounces of nuts, like peanuts, it improves the blood glucose control everyday as well as the blood lipids among people with type-2 diabetes.

“David Jenkins, MD, PhD, DSc, Principal Investigator and a pioneer in the area of glycemic control for diabetics said, “Nuts, including peanuts, can make a valuable contribution to the diabetic diet by displacing high glycemic index carbohydrates and replacing them with vegetable fats and vegetable proteins which have been shown in the long term to be associated with better cardiovascular health and diabetes prevention.” http://www.profitable.com/eating-nuts-such-as-peanuts-improves-diabetes-control-without-weight-gain/655196/

Peanuts are known to have more protein compared to any other nuts and a source of polyunsaturated oils. According to the report, the increase in proportion of fat and protein, especially those that originate in plants, may bestow metabolic benefits and decrease the risk of developing coronary heart disease and diabetes.

The study was entitled “Nuts as a Replacement for Carbohydrates in the Diabetic Diet” was conducted in University of Toronto. On the study, about 117 men and also women with type 2 diabetes were randomly grouped into three in which they received either a full portion of mixed nuts that includes peanuts, half portion of both nuts and also muffins, or full portion of muffins. Muffins were made of healthy whole wheat together with protein egg and skim milk powder. Fasting blood glucose of participants was tested every other week.

At the end of three months, the participants that received full portion of nuts showed the biggest decrease in glycated haemoglobin (HgA1c) which is a measure of blood glucose control. The disparity was considerably more than the decrease shown in the participants receiving the half portion of nuts and muffins, and in those exclusively receiving muffins. Peanut and tree nut ingestion also decreased total cholesterol and bad LDL cholesterol in the blood compared to the other groups. It is prominent that drops in HgA1c and LDL cholesterol were attained even though the common of the subjects were previously on antihyperglycemic medications and statins that lower cholesterol.

The author then concluded that nuts, like peanuts may be use to improve the diabetes control of the patients. Article says that weight preservation might have happen in nut eaters for a small number of reasons counting augmented resting metabolic rate, improved satiety resulting in decreased intake of other foods, or incomplete absorption of energy. Studies completed specially on peanut eaters have confirmed each of these factors.

“This new clinical trial is an important milestone demonstrating glycemic control and builds on an earlier population study published in JAMA in 2006. Researchers at the Harvard School of Public Health concluded, “Our findings suggest potential benefits of higher nut and peanut butter consumption in lowering the risk of type 2 diabetes in women.” http://www.profitable.com/eating-nuts-such-as-peanuts-improves-diabetes-control-without-weight-gain/655196/

The 2010 U.S. Dietary Guidelines called for Americans to change on the way to a more nutrient-dense, plant-based diet. Peanuts, peanut butter and nuts are foods to persuade daily.

The embryonic stem cell research may help for diabetics. There were some types of pancreatic cells that produce insulin which is a hormone needed to regulate the blood sugar. Anew medical type of implant can now help the sufferers of diabetes to control their blood sugar level.

The device will be implanted under the skin, a type of enveloped filled with embryonic stem cells, at which the cells become pancreatic cells. The company that will produce the implants is ViaCyte Inc., San Diego based.

According to Eugene Brandon, the company’s director said to the Los Angeles Times that the ViaCyte has already used the method to cure the diabetes in about hundreds of mice. They are essentially creating a replacement pancreas.

“ViaCyte hopes to begin human trials with the implants by 2013, with funding helped by $26 million in grants and loans from the California Institute of Regenerative Medicine, the state’s stem cell funding agency. Patients with Type 1 diabetes typically rely on insulin injections or an insulin pump to regulate their blood sugar. The approach works, but can be inconvenient and difficult to adhere to.” http://www.thirdage.com/news/embryonic-stem-cell-research-focuses-on-diabetes_06-01-2011

Dr. Vivian Fonseca, of Tulane University in New Orleans and the American Diabetes Association’s president-elect for medicine and and science stated to LA Times that what the people want is a single one time cure and she don’t see that happening in the future. She then added that the stem cell treatment might be a step into the right direction.

A new stay from Washington suggested that by sticking to vegetarian diet could help kidney disease patients avoid the accumulation of toxic levels of phosphorous in their bodies. The kidneys of the patients should have limited the consumption of phosphorous, as high level as the mineral that can lead to death and heart diseases.

Even as medical guidelines advise small phosphorus diets for patients with chronic kidney disease (CKD), phosphorus content is not programmed on food labels.

“Sharon Moe (Indiana University School of Medicine and Roudebush Veterans` Affairs Medical Center) and her colleagues studied the effects of vegetarian and meat-based diets on phosphorous levels in nine patients with CKD.” http://ayurveda.zeenews.com/story409.html

The patients were on vegetarian diet or a meat based diet for a week, and then followed by the opposite diet for two to four weeks later. The test for blood and urine were performed at the end of the week on both diets.

In spite of the equivalent protein and phosphorous concentration in both diets, the patients appears to have lower blood phosphorous levels and had a decrease phosphorous excretion in the urine when on vegetarian diet as compared to the meat based diet.

The author concluded that the study shows that the source of the protein in the diet has a significant effect on the level of phosphorous among patients with CKD.

The new study shows that type 2 diabetes is eight and a half times more common on children in the United States treated with growth hormone compared to kids who are not on the hormone treatment. Researchers based their study on the pharmaceutical company Eli Lilly and they found out that more than 11,000 kids who are on the treatment, 11 of them were diagnosed with type 2 diabetes after the treatment have started, while one got type 2 diabetes before the treatment started.

Additional 26 kids had a damage ability to process for blood sugar which is frequently precursor to type 2 diabetes. Children in the study received a growth hormone in a variety of condition that includes deficiency of the hormone, very short stature or genetic disorder like Prader-Willi syndrome or Turner syndrome. All the patients took Humatrope at some point in the treatment which is marketed by Eli Lilly. The company has been monitoring the growth hormone of the children in order to detect any unexpected side effect of the drug.

“The study, which is published in the Journal of Clinical Endocrinology and Metabolism, did not compare the children who took growth hormone to children with similar health conditions who did not take the hormone; rather, the researchers compared them to a large group of kids in the general population.” http://www.reuters.com/article/2011/05/13/us-growth-hormone-idUSTRE74C4PG20110513

According to Dr. Christopher Child, the lead author of the study and a researcher at Lilly Research Center in England told Reuters Health in an email that he was surprise to see a big portion of diabetes cases among the children who took growth hormone.

In 2000 study, a similar increased rate in diabetes had found out and the company noted some diabetes cases in reports of some potential side effects.

Growth hormone is identified to hinder with the activity of insulin, the hormone that regulates blood sugar. However it’s indistinct whether the growth hormone treatment itself is accountable for the higher diabetes risk seen in the kids. Child and his contemporaries institute that 10 of the 11 children with diabetes also had risk factors for the disease that included obesity, radiation treatment from leukemia, and some of the growth conditions themselves that encouraged the hormone treatment.

Child added that they are recommending closer surveillance of (growth hormone)-treated patients with pre-existing type 2 diabetes risk factors before, during and after treatment, to measure glucose metabolism and to hearten those lifestyle measures that have been revealed to be successful for anticipation of diabetes, such as diet and exercise

According to the study that was published online April 27 in the diabetes care, severe deficiency in vitamin D ca predict in an increased all-caused mortality to those patients with type 1 diabetes, but it is not linked with the microvascular complications in the kidney or the eye.

“Christel Joergensen, M.D., from the Steno Diabetes Center in Gentofte, Denmark, and colleagues assessed the role of vitamin D as a predictor for all-cause mortality, and the development of microvascular complications in the kidney and eye in 220 patients with newly diagnosed type 1 diabetes. Plasma vitamin D levels were determined using high-performance liquid chromatography/tandem mass spectrometry before patients developed microalbuminuria. Severe vitamin D deficiency was considered equal to or below the 10th percentile (15.5 mmol/L).” http://www.doctorslounge.com/index.php/news/pb/19941

Researchers found out that about 44 patients died during the 26 year median of the follow up period. After the adjustments in the cofounders, the hazard ration for the all cause mortality in 81 patients or 37% have developed microalbuminuria and have 27 or 12% have a progressed microalbuminuria.

With 192 patients or 87% have background retinopathy and have a progression to proliferative retinopathy that was seen among 34 individuals or 15%. The presence of severe deficiency in vitamin D at baseline did not predict in the development of the retinopathy or in the progression from the normoalbumiuria to the micro or macroalbuminuria.

According to the author, on the patients with type 1 diabetes, severe vitamin D deficiency independently predicts the all cause mortality but not in the development of the microvascular complications in the eye and in the kidney.